Latest Placebo-controlled study Stories
A comparison of several international clinical trials of beta-blocker drugs has shown there are notable differences in how well the drugs prevent deaths in heart failure patients, based on where the patients were treated.
TARRYTOWN, N.Y., July 28, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for the second quarter of 2011 and provided an update on development programs and upcoming milestones.
Adrenaline has kept its place in cardiac arrest guidelines despite limited evidence for or against its use.
TOKYO, July 22, 2011 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd.
Placebos are often referred to as â€œdummy pillsâ€ in research trials for new drug therapies, but whether or not placebos can actually influence objective measures of disease has been unclear.
ROCKVILLE, Md., June 27, 2011 /PRNewswire/ -- Glycotex, Inc., a clinical stage biopharmaceutical company, announced today that it has submitted the final results of the two completed Phase II clinical studies of its drug product candidate, GLYC-101 gel, to the clinicaltrials.gov database.
SAN DIEGO, June 24, 2011 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announce Phase III study results for linagliptin, demonstrating improved glycemic control in adults with type 2 diabetes (T2D) whose blood sugar is not adequately controlled.
PRAGUE, Czech Republic, June 24, 2011 /PRNewswire/ -- The randomised, double-blind, placebo-controlled multi-centre study (abstract no.
- A pivoted catch designed to fall into a notch on a ratchet wheel so as to allow movement in only one direction (e.g. on a windlass or in a clock mechanism), or alternatively to move the wheel in one direction.